Rare diseases
Investigational molecules
Locations
Back to Hungary68 clinical trials in Veszprem, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis
HungaryStudy on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy
HungaryStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
HungaryStudy on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction
HungaryStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms
HungaryStudy on Upadacitinib for Adults with Active Axial Spondyloarthritis
HungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for moderate to severe plaque psoriasis, including investigations of innovative therapies like JNJ-77242113 and ESK-001.
Multiple trials focusing on efficacy assessment and treatment response durability.
Extensive research into psoriatic arthritis treatments, including trials with zasocitinib, sonelokimab, and deucravacitinib for both biologic-naïve and experienced patients.
Focus on reducing symptoms and improving quality of life for patients.
Innovative research targeting systemic lupus erythematosus and other inflammatory conditions, with studies on medications like GLPG3667 and upadacitinib.
Comprehensive evaluation of disease activity and treatment responses.
Studies examining treatments for knee osteoarthritis, including comparative analysis of different chondroitin sulfate formulations and novel compounds.
Focus on both symptom management and functional outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
